Strategic Analysis Of Glaxosmithkline 's Foreign Market Expansion And International Operations

1138 Words Oct 27th, 2016 5 Pages
This is a strategic analysis of GlaxoSmithKline that examines the key factors that influence the company and its activities. The strategic analysis will examine key factors in the company’s internal and external environment and their influence on the company’s strategies. GlaxoSmithKline is a global healthcare company that offers pharmaceutical, vaccines and consumer products. The company is a product of various mergers, the latest occurring in 2001 between GlaxoWellcome and SmithKline Beecham. The company started in London United Kingdom in 1715 as Plough Court pharmacy and has evolved to become one of the leading global healthcare companies. The healthcare company operates in more than 150 countries with 89 manufacturing locations and research centers in the USA, China, UK and Belgium. In 2015, the company’s sales grew to £23.9 billion from £23.0 billion in 2014 (GlaxoSmithKline plc. 2015).
There are various factors that play a critical role in GlaxoSmithKline’s foreign market expansion and international operations. These factors are based on the SWOT analysis in appendix 1. A SWOT analysis, also known as situational analysis, is a strategic analysis tool that evaluates the position of a firm by identifying strengths, weaknesses, opportunities and threats. According to Daniels, Radebaugh and Sullivan (2014,) SWOT analysis forms the basis of strategic planning when firms engage in international operations. A good strategy is one that focuses more on exploiting strengths…
Open Document